Skip to main content
logo
Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
6.62
-0.15 (-2.22%)
Oct 16, 2026, 4:00 PM EDT - Market closed

Eupraxia Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
4363811121115828
Market Cap Growth
42.44%241.41%0.65%90.50%111.19%-
Enterprise Value
33132210296438
Last Close Price
6.627.553.174.162.692.30

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
3.364.743.51124.328.081.83
P/TBV Ratio
4.287.2965.7050.067.481.75

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.000.0011.711.250.52
Net Debt / Equity Ratio
-1.02-1.00-1.04-9.96-1.29-1.04
Net Debt / EBITDA Ratio
2.322.101.230.320.531.12
Net Debt / FCF Ratio
3.452.761.100.430.631.31
Quick Ratio
15.7114.4410.741.016.0013.38
Current Ratio
16.0015.1211.101.026.0813.49
Return on Equity (ROE)
-66.70%-68.76%-157.31%-715.19%-178.04%-
Return on Assets (ROA)
-43.66%-39.67%-61.14%-88.37%-52.20%-68.51%
Return on Capital Employed (ROCE)
-43.50%-47.70%-84.80%-3120.70%-109.70%-61.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-12.09%-10.12%-22.84%-25.44%-31.75%-68.66%
FCF Yield
-8.77%-7.64%-26.96%-18.77%-25.12%-43.73%
Buyback Yield / Dilution
-47.80%-17.76%-40.52%-25.21%-55.45%-102.75%
SEC Filings: 10-K · 10-Q